SEC Filings

SEC Filings

Filing date	Description	Form	View
Jun 15, 2018	Statement of changes in beneficial ownership of securities	4	View HTML 0000904454-18-000426.pdf 0000904454-18-000426.rtf 0000904454-18-000426.xls
Jun 14, 2018	Statement of changes in beneficial ownership of securities	4	View HTML 0001214659-18-004464.pdf 0001214659-18-004464.rtf 0001214659-18-004464.xls
Jun 14, 2018	Statement of changes in beneficial ownership of securities	4	View HTML 0001214659-18-004465.pdf 0001214659-18-004465.rtf 0001214659-18-004465.xls
Jun 14, 2018	Statement of changes in beneficial ownership of securities	4	View HTML 0001214659-18-004466.pdf 0001214659-18-004466.rtf 0001214659-18-004466.xls
Jun 14, 2018	Statement of changes in beneficial ownership of securities	4	View HTML 0001214659-18-004467.pdf 0001214659-18-004467.rtf 0001214659-18-004467.xls
Jun 14, 2018	Statement of changes in beneficial ownership of securities	4	View HTML 0001214659-18-004468.pdf 0001214659-18-004468.rtf 0001214659-18-004468.xls
Jun 14, 2018	Statement of changes in beneficial ownership of securities	4	View HTML 0001214659-18-004469.pdf 0001214659-18-004469.rtf 0001214659-18-004469.xls
Jun 12, 2018	An amendment to a SC 13D filing	SC 13D/A	View HTML 0001144204-18-033922.pdf 0001144204-18-033922.rtf 0001144204-18-033922.xls
Jun 08, 2018	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	424B5	View HTML 0001104659-18-039067.pdf 0001104659-18-039067.rtf 0001104659-18-039067.xls
Jun 08, 2018	Report of unscheduled material events or corporate event	8-K	View HTML 0001104659-18-039069.pdf 0001104659-18-039069.rtf 0001104659-18-039069.xls

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE